FPF
CLCD

FNY Partners Fund’s CoLucid Pharmaceuticals, Inc. CLCD Stock Holding History

FNY Partners Fund’s Portfolio CLCD Stock Details CLCD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-1,200
Closed -$55K – 1476
2017
Q1 		$55K Buy
+1,200
New +$51.9K 0.01% 687

FNY Partners Fund's CLCD Position: Q2 2017 in Review

FNY Partners Fund sold out of CoLucid Pharmaceuticals, Inc. (CLCD) in Q2 2017, closing a stake of 1,200 shares — an estimated $55K sold.

FNY Partners Fund first reported a position in CLCD in Q1 2017 and held it in 1 quarter. The position peaked at $55K in Q1 2017. 0 funds tracked by Wall St. Rank hold CLCD as of Q2 2017.

  • FNY Partners Fund reported no remaining CoLucid Pharmaceuticals, Inc. position as of Q2 2017 after selling out during the quarter.
  • FNY Partners Fund sold 1,200 CoLucid Pharmaceuticals, Inc. shares in Q2 2017, an estimated $55K.
  • FNY Partners Fund first reported a position in CoLucid Pharmaceuticals, Inc. in Q1 2017 and held it in 1 quarter.
  • FNY Partners Fund's CoLucid Pharmaceuticals, Inc. position peaked at $55K in Q1 2017.
  • 0 funds tracked by Wall St. Rank held CoLucid Pharmaceuticals, Inc. as of Q2 2017.

Based on FNY Partners Fund's 13F filing for Q2 2017, filed 10 Aug 2017.